147 related articles for article (PubMed ID: 15025337)
1. Serum pooling for screening of blood donors for hepatitis C virus antibody.
Kini S; Kumar S; Sharma RR; Thakral B; Agnihotri SK
Indian J Pathol Microbiol; 2003 Jul; 46(3):537-8. PubMed ID: 15025337
[No Abstract] [Full Text] [Related]
2. Hepatitis C virus infection in blood donors: to screen or not to screen?
Anand AC; Dhot PS; Ohri VC
Natl Med J India; 1997; 10(6):304-5. PubMed ID: 9481109
[No Abstract] [Full Text] [Related]
3. Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors.
Piazza M; Chien D; Quan S; Houghton M
Boll Soc Ital Biol Sper; 1996; 72(1-2):69-70. PubMed ID: 8868116
[No Abstract] [Full Text] [Related]
4. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
Bagga PK; Singh SP
Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
[TBL] [Abstract][Full Text] [Related]
6. [Seroepidemiologic study on the feasibility of screening for the antibody to HCV by pooling the serum specimens].
Liu P; Shu H; Zhang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):179-81. PubMed ID: 7530601
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.
Sarov B; Novack L; Beer N; Safi J; Soliman H; Pliskin JS; Litvak E; Yaari A; Shinar E
Transfus Med; 2007 Dec; 17(6):479-87. PubMed ID: 17727618
[TBL] [Abstract][Full Text] [Related]
10. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
12. Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels.
Sarov B; Novack L; Galai N; Yaari A; Orgel M; Safi J; Yahalom V; Shinar E
Clin Microbiol Infect; 2007 Jul; 13(7):737-9. PubMed ID: 17441976
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pooled screening for anti-HCV in two blood services set-ups.
Novack L; Shinar E; Safi J; Soliman H; Yaari A; Galai N; Pliskin JS; Sarov B
Trop Med Int Health; 2007 Mar; 12(3):415-21. PubMed ID: 17313513
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C infection in first-time blood donors in Karachi--a possible subgroup for sentinel surveillance.
Abdul Mujeeb S; Nanan D; Sabir S; Altaf A; Kadir M
East Mediterr Health J; 2006 Nov; 12(6):735-41. PubMed ID: 17333817
[TBL] [Abstract][Full Text] [Related]
15. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
[TBL] [Abstract][Full Text] [Related]
16. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C--screening of blood donations.
Walsh TJ
Ir Med J; 1991 Jun; 84(2):41-2. PubMed ID: 1716620
[No Abstract] [Full Text] [Related]
18. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening.
Vogt M; Mühlbauer F; Braun SL; Lang T; Busch R; Lange R; Frösner G; Hess J
Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
